Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

NCT00107653

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Scottsdale, Arizona, United States
  • Tucson, Arizona, United States
  • Anaheim, California, United States
  • Fountain Valley, California, United States
View all 60 locations
View Trial Details
Completed

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

NCT00700401

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Vitória, Espírito Santo, Brazil
  • Brasília, Federal District, Brazil
  • São Luís, Maranhão, Brazil
  • Rio de Janeiro, Brazil
View Trial Details
Completed

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

NCT01525628

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.27.0006 Boehringer Ingelheim Investigational Site La Mesa, California, United States
  • 1241.27.0005 Boehringer Ingelheim Investigational Site Rockville, Maryland, United States
  • 1241.27.0004 Boehringer Ingelheim Investigational Site Marlton, New Jersey, United States
  • 1241.27.0003 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States
View all 16 locations
View Trial Details
Completed

Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions

NCT02418494

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • University of California at San Francisco - Comprehensive Cancer Center San Francisco, California, United States
  • Anal Dysplasia Clinic Chicago, Illinois, United States
  • Cornell Clinical Trials Unit New York, United States
  • Laser Surgery Care New York, United States
View Trial Details
Completed

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

NCT01475838

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Spectrum Medical Group Phoenix, Arizona, United States
  • Pueblo Family Physicians Phoenix, Arizona, United States
  • AIDS Healthcare Foundation Beverly Hills, California, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
View all 99 locations
View Trial Details

Related conditions